Diversity and plasticity of self recognition during the development of multiple sclerosis

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1682-1690

  Tuohy, Vincent K ^a,b   Yu, Min ^a   Weinstock Guttman, Bianca ^b   Kinkel, R Philip ^b  

^a Research Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

autoimmunity; demyelination; encephalomyelitis; myelin proteolipid protein; T cell epitopes

Indexed keywords

MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; DEMYELINATION; ENCEPHALOMYELITIS; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030899404     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119331     Document Type: Article

References (50)

1. Martin, R., H.F. McFarland, and D.E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153-187.
2. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
3. Baxevanis, C.N., G.J. Reclos, C. Servis, E. Anastasopoulos, P. Arsenis, A. Katsiyiannis, N. Matikas, J.D. Lambris, and M. Papamichail. 1989. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 22:23-30.
4. Richert, J.R., E.D. Robinson, G.E. Deibler, R.E. Martenson, L.J. Dragovic, and M.W. Kies. 1989. Evidence for multiple human T cell recognition sites on myelin basic protein. J. Neuroimmunol. 23:55-66.
5. Allegretta, M., J.A. Nicklas, S. Sriram, and R.J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science (Wash. DC). 247:718-721.
6. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (Lond.). 346:183-187.
7. Pette, M., K. Fujita, D. Wilkinson, D.M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J.T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87:7968-7972.
8. Martin, R., U. Utz, J.E. Coligan, J.R. Richert, M. Flerlage, E. Robinson, R. Stone, W.E. Biddison, D.E. McFarlin, and H.F. McFarland. 1992. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359-1366.
9. Sun, J.-B., T. Olsson, W.-Z. Wang, B.-G. Xiao, V. Kostulas, S. Fredrikson, H.-P. Ekre, and H. Link. 1991. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1461-1468.
10. Trotter, J.L., W.F. Hickey, R.C. van der Veen, and L. Sulze. 1991. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J. Neuroimmunol. 33:55-62.
11. Chou, Y.K., D.N. Bourdette, H. Offner, R. Whitham, R.Y. Wang, G.A. Hashim, and A.A. Vandenbark. 1992. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:105-113.
12. Kerlero de Rosbo, N., R. Milo, M.B. Lees, D. Burger, C.C. Bernard, and A. Ben-Nun. 1993. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602-2608.
13. Zhang, Y., D. Burger, G. Saruhan, M. Jeannet, and A.J. Steck. 1993. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Neurology. 43:403-407.
14. Clayton, J.P., G.M. Gammon, D.G. Ando, D.H. Kono, L. Hood, and E.E. Sercarz. 1989. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169:1681-1691.
15. McCarron, R.M., R.J. Fallis, and D.E. McFarlin. 1990. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:73-79.
16. Perry, L.L., E. Barzaga-Gilbert, and J.L. Trotter. 1991. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 33:7-15.
17. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Sercarz. 1992. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature (Lond.). 358:155-157.
18. Cross, A.H., V.K. Tuohy, and C.S. Raine. 1993. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261-269.
19. McRae, B.L., C.L. Vanderlugt, M.C. Dal Canto, and S.D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
20. Yu, M., J.M. Johnson, and V.K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
21. Morrissey, S.P., D.H. Miller, B.E. Kendall, D.P. Kingsley, M.A. Kelly, D.A. Francis, D.G. MacManus, and W.I. McDonald. 1993. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain. 116:135-146.
22. Filippi, M., M.A. Horsfield, S.P. Morrissey, D.G. MacManus, P. Rudge, W.I. McDonald, and D.H. Miller. 1994. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 44:635-641.
23. Beck, R.W., P.A. Cleary, J.D. Trobe, D.I. Kaufman, M.J. Kupersmith, D.W. Paty, and C.H. Brown. 1993. The effect of corticosteroid for acute optic neuritis on the subsequent development of multiple sclerosis. N. Eng. J. Med. 329:1764-1769.
24. Poser, C.M., D.W. Paty, L. Scheinberg, W.I. McDonald, F.A. Davis, G.C. Ebers, K.P. Johnson, W.A. Sibley, D.H. Silberberg, and W.W. Tourtellotte. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:227-231.
25. Milner, R.J., C. Lai, K.-A. Nave, D. Lenoir, J. Ogata, and J.G. Sutcliffe. 1985. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 42:931-939.
26. Macklin, W.B., C.W. Campagnoni, P.L. Deininger, and M.V. Gardinier. 1987. Structure and expression of the mouse myelin proteolipid protein gene. J. Neurosci. Res. 18:383-394.
27. Geysen, H.M., S.J. Rodda, T.J. Mason, G. Tribbick, and P.G. Schoofs. 1987. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods. 102:259-274.
28. Maeji, N.J., A.M. Bray, and H.M. Geysen. 1990. Multi-pin peptide synthesis strategy for T cell determinant analysis. J. Immunol. Methods. 134:23-33.
29. Gammon, G., H.M. Geysen, R.J. Apple, E. Pickett, M. Palmer, A. Ametani, and E.E. Sercarz. 1991. T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J. Exp Med. 173:609-617.
30. 1S. J. Immunol. 152:3711-3719.
31. Kaufman, D.L., M. Clare-Salzler, J. Tian, T. Forsthuber, G.S. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.). 366:69-72.
32. Novotny, J., R.E. Bruccoleri, W.D. Carlson, M. Handschumacher, and E. Haber. 1987. Antigenicity of myohemerythrin. Science (Wash. DC). 238: 1584-1586.
33. Folch, J., M. Lees, and G.H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226:497-509.
34. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1523-1526.
35. Tuohy, V.K. 1994. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. Neurochem. Res. 19: 935-944.
36. Allen, M., M. Sandberg-Wollheim, K. Sjogren, H.A. Erlich, U. Petterson, and U. Gyllensten. 1994. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Human Immunol. 39: 41-48.
37. + T cells from multiple sclerosis patients. J. Neuroimmunol. 46:33-42.
38. + T cells from multiple sclerosis patients. J. Neuoroimmunol. 53:153-161.
39. Markovic-Plese, S., H. Fukaura, J. Zhang, A. Al-Sabbagh, S. Southwood. A. Sette, V.K. Kuchroo, and D.A. Hafler. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155:982-992.
40. Zhang, J., C. Vandevyver, P. Stinissen, and J. Raus. 1995. In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J. Immunol. 155:5868-5877.
41. Pelfrey, C.M., L.R. Tranquill, S.A. Boehme, H.F. McFarland, and M.J. Lenardo. 1995. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154:6191-6202.
42. Tanaka, H., K. Ota, M. Ikusaka, M. Ejima, and S. Mamyama. 1995. Expression of Fas-antigen on T cells in multiple sclerosis. Rinsho Shinkeigaku Clin. Neurol. (Tokyo). 35:299-301.
43. Rieckmann, P., M. Albrecht, B. Kitze, T. Weber, H. Tumani, A. Broocks, W. Luer, A. Helwig, and S. Poser. 1995. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:82-88.
44. Correale, J., W. Gilmore, M. McMillan, S. Li, K. McCarthy, T. Le, and L.P. Weiner. 1995. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol 154:2959-2968.
45. Soderstrom, M., H. Link, S. Fredrikson, and J.-B. Sun. 1994. Optic neuritis and multiple sclerosis: the T cell repertoires to myelin proteins and MBP peptides change with time. Acta Neurol. Scand. 90:10-18.
46. Kennedy, M.K., L.-J. Tan, M.C. Dal Canto, V.K. Tuohy, Z. Lu, J.L. Trotter, and S.D. Miller. 1990. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein (PLP) and its encephalitogenic peptides. J. Immunol. 144:909-915.
47. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
48. '48. Samson, M.F., and D.E. Smilek. 1995. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J. Immunol. 155:2737-2746.
49. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (Lond.). 379:343-346.
50. Franco, A., S. Southwood, T. Arrhenius, V.K. Kuchroo, H.M. Grey, A. Sette, and G.Y. Ishioka. 1994. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24:940-946.